A comparison of gene expression levels (Tang et al., 2017) in normal adrenal gland samples and ACC samples showed that SYTL5 mRNA expression is significantly reduced in tumour samples (Figure 6B). The gene discussed is SYTL5; the disease is adrenal cortex carcinoma.